logo
科言猫学术研究的AI总结
language
手机端手机端
  • Phone Feature微信小程序
简体中文简体中文
notice消息通知
博客博客
arrow
L

Luc Cabel

université psl
H指数:30
被引数:3,902

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Tumor-on-chip as a personalized platform for rapid drug testing in breast cancer

芯片肿瘤作为乳腺癌个性化快速药物测试平台

Cell Reports Medicine
IF10.6
2026-09-010
OAAI
Helal, Clara; Pinon, Lea; Jin, Juliette; Schintu, Niccolo; Vazquez, Ana; Domalain, Lena; Nurmik, Martin; Antonelli, Gianni; Ladaigue, Segolene; Simon, Maxime; Montaudon, Elodie; Sourd, Laura; Derrien, Heloise; Zalcman, Gerard; Bellini, Angela; Goncalves, Andreia; Vincent-Salomon, Anne; Ramtohul, Toulsie; Marangoni, Elisabetta; Parrini, Maria Carla; Cabel, Luc; Descroix, Stephanie
PROMENADE: pembrolizumab for early ER-low/HER2-negative breast cancer, real-world French cohort

PROMENADE研究：早期ER低表达/HER2阴性乳腺癌患者接受pembrolizumab治疗的真实世界法国队列研究

ESMO Open
IF8.3
2025-11-250
OAAI
F. Cherifi; L. Cabel; C. Bousrih; E. Volant; F. Dalenc; B. Mery; M. Auvray Kuentz; A. Mailliez; S. Ladoire; A. Tassin de Nonneville; M. Alexandre; L. Benistant; M. Leheurteur; C. Bailleux; M. Debled; J.-S. Frenel; D. Loirat; E. Bastien; Q. Aussedat; F.C. Bidard
Prognostic significance of early on-treatment evolution of circulating tumor DNA in advanced ER+/HER2- breast cancer

早期治疗期间循环肿瘤DNA的演变在晚期ER+/HER2-乳腺癌中的预后意义

Annals of Oncology
IF65.4
2025-07-050
PRE
A. Mamann; Y. Pradat; F.C. Bidard; S. Delaloge; L. Cabel; I. Faull; S. Marques; T. Bachelot; F. Dalenc; T. de la Motte Rouge; B. Pistilli; J. Samaniego; J.S. Frenel; C. Levy; J.M. Ferrero; R. Sabatier; S. Ladoire; C. Chakiba; A.C. Hardy; J. Lemonnier; Y. Mahi; F. Andre; P.H. Cournede; S. Michiels; E. Bernard
Deciphering molecular relapse and intra-tumor heterogeneity in non-metastatic resectable head and neck squamous cell carcinoma using circulating tumor DNA
ORAL ONCOLOGY
IF3.9
2025-01-010
PRE
Marret, Gregoire; Lamy, Constance; Vacher, Sophie; Cabel, Luc; Sene, Mathieu; Ahmanache, Ladidi; Courtois, Laura; El Beaino, Zakhia; Klijanienko, Jerzy; Martinat, Charlotte; Servant, Nicolas; Kamoun, Choumouss; Halladjian, Maral; Bronzini, Thierry; Balsat, Cedric; Laes, Jean-Francois; Prevot, Aubray; Sauvage, Sebastien; Lienard, Maxime; Martin, Emmanuel; Genin, Berengere; Badois, Nathalie; Lesnik, Maria; Dubray-Vautrin, Antoine; Choussy, Olivier; Ghanem, Wahib; Taouachi, Rabah; Planchon, Julien Masliah; Bieche, Ivan; Le Tourneau, Christophe; Kamal, Maud
Use of Pretreatment Perfusion MRI-based Intratumoral Heterogeneity to Predict Pathologic Response of Triple-Negative Breast Cancer to Neoadjuvant Chemoimmunotherapy
RADIOLOGY
IF15.2
2024-09-010
PRE
Ramtohul, Toulsie; Lepagney, Victoire; Bonneau, Claire; Jin, Maxime; Menet, Emmanuelle; Sauge, Juliette; Laas, Enora; Romano, Emanuela; Bello-Roufai, Diana; Mechta-Grigoriou, Fatima; Salomon, Anne Vincent; Bidard, Francois-Clement; Langer, Adriana; Malhaire, Caroline; Cabel, Luc; Brisse, Herve J.; Tardivon, Anne
Is capecitabine (CAPE) the best treatment (trt) option for estrogen receptor-positive (ER+) HER2-negative (HER2-) metastatic breast cancer (MBC) after progression on endocrine treatment (ET): An analysis of the ESME real-world database

卡培他滨（CAPE）是否是内分泌治疗（ET）进展后雌激素受体阳性（ER+）人表皮生长因子受体2阴性（HER2-）转移性乳腺癌（MBC）的最佳治疗（trt）选择：一项基于ESME真实世界数据库的分析

ANNALS OF ONCOLOGY
IF65.4
2024-09-010
PRE
Pflumio, C.; Carton, M.; Debled, M.; Cottu, P. H.; Leheurteur, M.; Dalenc, F.; Jacot, W.; Mailliez, A.; Sauterey, B.; Levy, C.; Kaderbhai, C.; Tredan, O.; Goncalves, A.; Uwer, L.; Robert, M.; Bailleux, C.; Cabel, L.; Delaloge, S.; Bosquet, L.; Petit, T.
Efficacy of administration sequence: Sacituzumab Govitecan and Trastuzumab Deruxtecan in HER2-low metastatic breast cancer
BRITISH JOURNAL OF CANCER
IF6.8
2024-06-256
PRE
Poumeaud, F.; Morisseau, M.; Cabel, L.; Goncalves, A.; Rivier, C.; Tredan, O.; Volant, E.; Frenel, J. -s.; Ladoire, S.; Jacot, W.; Jamelot, M.; Foka Tichoue, H.; Patsouris, A.; Teixeira, L.; Bidard, F. -c.; Loirat, D.; Brunet, M.; Levy, C.; Bailleux, C.; Cabarrou, B.; Deleuze, A.; Uwer, L.; Deluche, E.; Grellety, T.; Franchet, C.; Fiteni, F.; Bischoff, H.; Vion, R.; Pagliuca, M.; Verret, B.; Becourt, S.; Reverdy, T.; de Nonneville, A.; Dalenc, F.

研究方向

暂未获取到该数据
F
François‐Clément Bidard
H 指数:66论文数:545被引数:1.6万
J
Jean‐Yves Pierga
H 指数:79论文数:719被引数:2.9万
C
Christelle Lévy
H 指数:46论文数:389被引数:1.0万
A
Anthony Gonçalvès
H 指数:61论文数:730被引数:1.9万
I
Ivan Bièche
H 指数:95论文数:1,216被引数:3.4万
D
Delphine Loirat
H 指数:39论文数:304被引数:7,324
C
Charlotte Proudhon
H 指数:32论文数:124被引数:3,798
P
Paul Cottu
H 指数:53论文数:529被引数:1.0万
F
Florence Dalenc
H 指数:55论文数:561被引数:1.6万
M
Marc Debled
H 指数:42论文数:373被引数:8,197